Sam Griffith
Overview
Explore the profile of Sam Griffith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
918
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Psaros C, Goodman G, Lee J, Rice W, Kelley C, Oyedele T, et al.
J Int AIDS Soc
. 2024 May;
27(5):e26252.
PMID: 38783534
Introduction: HPTN 083 demonstrated the superiority of long-acting cabotegravir (CAB-LA) versus daily oral emtricitabine/tenofovir disoproxil fumarate (TDF/FTC) as pre-exposure prophylaxis (PrEP) among cisgender men and transgender women who have sex...
2.
Yang B, Sloot R, Floyd S, Awoniyi D, Griffith S, Ayles H, et al.
J Acquir Immune Defic Syndr
. 2023 Mar;
93(4):300-304.
PMID: 37001128
Background: Unknown HIV status and consequent low antiretroviral treatment coverage among men living with HIV combined with high-risk behavior is a key driver of the HIV epidemic in high-burden settings....
3.
Macleod D, Shanaube K, Skalland T, Limbada M, Mandla N, Bwalya J, et al.
Lancet HIV
. 2022 Nov;
9(11):e751-e759.
PMID: 36332652
Background: In 2014, UNAIDS set the target that 90% of individuals on antiretroviral therapy (ART) be virally suppressed. Here, we use data from the HPTN 071 (PopART) trial to report...
4.
Floyd S, Shanaube K, Yang B, Schaap A, Griffith S, Phiri M, et al.
PLoS Med
. 2020 Apr;
17(4):e1003067.
PMID: 32240156
Background: In 2014, the Joint United Nations Programme on HIV/AIDS (UNAIDS) set the 90-90-90 targets: that 90% of people living with HIV know their HIV status, that 90% of those...
5.
Hayes R, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, et al.
N Engl J Med
. 2019 Jul;
381(3):207-218.
PMID: 31314965
Background: A universal testing and treatment strategy is a potential approach to reduce the incidence of human immunodeficiency virus (HIV) infection, yet previous trial results are inconsistent. Methods: In the...
6.
Floyd S, Ayles H, Schaap A, Shanaube K, Macleod D, Phiri M, et al.
PLoS One
. 2018 Aug;
13(8):e0197904.
PMID: 30096139
Background: HPTN071(PopART) is a 3-arm community-randomised study in 21 peri-urban/urban communities in Zambia and the Western Cape of South Africa, with high HIV prevalence and high mobility especially among young...
7.
Bock P, Phiri C, Piwowar-Manning E, Kosloff B, Mandla N, Young A, et al.
J Int AIDS Soc
. 2017 Sep;
20(Suppl 6):21780.
PMID: 28872272
Introduction: Population-wide HIV testing services (HTS) must be delivered in order to achieve universal antiretroviral treatment (ART) coverage. To accurately deliver HTS at such scale, non-facility-based HIV point-of-care testing (HIV-POCT)...
8.
Shanaube K, Schaap A, Floyd S, Phiri M, Griffith S, Chaila J, et al.
AIDS
. 2017 May;
31(11):1555-1564.
PMID: 28471766
Objective: To determine the uptake of home-based HIV counselling and testing (HCT) in four HPTN 071 (PopART) trial communities (implementing a 'full' combination HIV prevention package that includes universal HIV...
9.
Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, et al.
PLoS Med
. 2017 May;
14(5):e1002292.
PMID: 28464041
Background: The Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 targets require that, by 2020, 90% of those living with HIV know their status, 90% of known HIV-positive individuals receive...
10.
Chen I, Zhang Y, Cummings V, Cloherty G, Connor M, Beauchamp G, et al.
AIDS Res Hum Retroviruses
. 2017 Apr;
33(7):745-748.
PMID: 28384058
Resistance to reverse transcriptase and protease inhibitors was frequently detected in HIV from black men who have sex with men (MSM) enrolled in the HIV prevention trials network (HPTN) 061...